Chengdu Olymvax Biopharmaceuticals Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 15 76 179 320 487 547 496 589
Przychód Δ r/r 0.0% -83.2% 401.7% -61.5% 8947.9% 423.1% 134.6% 78.7% 52.2% 12.4% -9.4% 18.7%
Marża brutto 99.2% 99.0% 99.3% 99.5% 80.1% 84.7% 91.5% 95.1% 93.9% 92.9% 100.0% 94.9%
EBIT (mln) -24 -25 -53 -56 -29 -21 -24 49 102 69 3 21
EBIT Δ r/r 0.0% 6.4% 111.0% 5.1% -48.9% -25.6% 11.9% -304.9% 108.7% -31.9% -95.1% 526.3%
EBIT (%) -4757.0% -30160.4% -12683.3% -34643.3% -195.5% -27.8% -13.3% 15.2% 20.9% 12.6% 0.7% 3.6%
Koszty finansowe (mln) 0 0 0 0 0 0 0 1 1 4 0 15
EBITDA (mln) -16 -15 -37 -47 -14 -1 -6 66 143 94 3 50
EBITDA(%) -3143.2% -18307.6% -8756.5% -28925.4% -98.2% -1.3% -3.3% 20.7% 29.4% 17.3% 0.7% 8.4%
Podatek (mln) 3 3 0 0 0 0 0 13 -1 17 -1 7
Zysk Netto (mln) -23 -25 -52 -56 -27 -19 -31 24 108 27 17 21
Zysk netto Δ r/r 0.0% 7.3% 110.0% 6.1% -50.9% -30.2% 63.3% -176.0% 357.9% -75.4% -34.5% 19.2%
Zysk netto (%) -4664.3% -29835.1% -12485.6% -34430.8% -186.7% -24.9% -17.3% 7.4% 22.2% 4.9% 3.5% 3.5%
EPS 0.0 0.0 -0.31 -0.29 -0.13 -0.0924 -0.0766 0.0582 0.27 0.0656 0.0429 0.0512
EPS (rozwodnione) 0.0 0.0 -0.31 -0.29 -0.13 -0.0924 -0.0766 0.0582 0.27 0.0656 0.0429 0.0512
Ilośc akcji (mln) 0 0 169 191 203 206 405 405 405 405 406 405
Ważona ilośc akcji (mln) 0 0 169 191 203 206 405 405 405 405 406 405
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY